Autolus Therapeutics plc (AUTL) Balance Sheet
As of 2026-06-30 (10-Q), Autolus Therapeutics plc (AUTL) reported total assets of $493.2M, total liabilities of $418.4M and shareholders' equity of $74.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $171.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AUTLAutolus Therapeutics plcFollow AUTL — free
—
Price chart with a free account
- Market cap
- 409.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2017 Sep 17 | FY2017 Dec 17 | FY2018 Sep 18 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Mar 22 | FY2022 Jun 22 | FY2022 Sep 22 | FY2022 Dec 22 | FY2023 Mar 23 | FY2023 Jun 23 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 137.1 | 129.0 | 247.1 | 217.6 | 211.4 | 154.1 | 310.7 | 268.6 | 216.4 | 163.1 | 382.4 | 343.0 | 307.5 | 239.6 | 227.4 | 104.1 | 171.4 | |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 360.6 | 196.6 | 30.2 | |
| Receivables | — | — | — | — | — | — | 0.0 | — | — | — | 0.1 | — | — | 0.1 | 0.0 | 24.0 | 44.4 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 4.1 | 33.2 | 33.4 | |
| Current assets | 142.5 | — | 259.3 | 233.0 | 249.3 | 197.0 | 347.0 | 309.5 | 259.0 | 212.3 | 425.8 | 393.9 | 355.4 | 275.3 | 660.9 | 435.9 | 336.1 | |
| Total assets | 148.7 | 142.7 | 273.2 | 254.2 | 303.5 | 294.2 | 405.6 | 364.0 | 314.0 | 263.8 | 490.3 | 460.0 | 451.0 | 375.4 | 782.7 | 589.1 | 493.2 | |
| Current liabilities | 5.0 | — | 17.1 | 21.1 | 25.0 | 33.6 | 28.6 | 28.8 | 35.5 | 38.8 | 46.4 | 39.6 | 41.1 | 44.7 | 60.7 | 73.4 | 68.8 | |
| Long-term debt | 0.8 | — | 0.4 | 0.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 6.1 | — | 17.7 | 21.6 | 48.7 | 84.2 | 92.2 | 92.9 | 99.5 | 102.7 | 191.6 | 193.1 | 221.7 | 263.9 | 355.4 | 410.9 | 418.4 | |
| Shareholders' equity | 142.6 | 137.5 | 255.5 | 232.6 | 254.8 | 210.0 | 313.3 | 271.1 | 214.5 | 161.2 | 298.7 | 266.9 | 229.3 | 111.5 | 427.3 | 178.1 | 74.8 |
USD millions · SEC XBRL
Autolus Therapeutics plc — questions
- How much cash does Autolus Therapeutics plc have?
- $171.4M in cash and cash equivalents as of 2026-06-30.
- What are Autolus Therapeutics plc's total assets?
- $493.2M as of 2026-06-30.
- What is Autolus Therapeutics plc's shareholders' equity?
- $74.8M as of 2026-06-30.
Every figure on this page comes from Autolus Therapeutics plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.